Serum Institute gets CDSCO Panel nod to conduct phase III clinical trial of Yellow Fever Vaccine Dr. Divya Colin19 Jan 2025 6:00 PM ISTNew Delhi: Noting the interim results of the Phase II clinical trial of Yellow Fever Vaccine, the Subject Expert Committee (SEC), functional under the...
Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs Farhat Nasim17 Jan 2023 2:04 PM ISTNew Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...
CDSCO panel recommends market authorization for Covovax jab as heterologous booster dose MD Bureau13 Jan 2023 3:21 PM ISTNew Delhi: An expert panel of the central drugs regulatory authority is likely to take a decision on Wednesday on granting market authorisation to...
Biotechnology major Biocon net profit declines 11 percent to Rs 168 crore in Q2 Ruchika Sharma15 Nov 2022 2:30 PM ISTMazumdar-Shaw said the consolidation of Viatris' global biosimilars business and the strategic vaccines alliance with Serum Institute will add to the...
Serum Institute of India plans to manufacture Ebola vaccine for use in Uganda outbreak Ruchika Sharma19 Oct 2022 2:30 PM ISTThe source said the Ebola vaccine doses would be supplied free of cost.
Meet 52 richest Indians in Pharma Healthcare domain Farhat Nasim21 Sept 2022 7:33 PM ISTNew Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...
Health Bulletin 9/April/2022 Roshni Dhar9 April 2022 5:48 PM ISTHere are the top health stories for today:Free PG Medical Courses In Non-Clinical Areas: Telangana Contrary to the general notion...
Serum Institute files for full CDSCO approval of Covishield Ruchika Sharma1 Jan 2022 1:01 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market...
Immunization efforts in India, lower, middle income countries to strengthen with Covovax approval, says SII Ruchika Sharma29 Dec 2021 2:14 PM ISTCovovax is produced by Pune-based SII under licence from Novavax.
CDSCO allows Serum Institute to enrol 7-11 year-olds in COVID vaccine trial Ruchika Sharma28 Sept 2021 12:30 PM ISTBengaluru: India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its COVID-19 vaccine trial as the...
Top Govt panel calls for 12-16 week gap between Covishield doses Farhat Nasim13 May 2021 1:57 PM ISTNew Delhi: Seeking to alter the interval between Serum Institue of India's Covid-19 vaccine doses, a government panel, National Technical Advisory...
COVID Vaccination in India- Developments and Controversies Medical Dialogues Team26 April 2021 8:08 PM ISTNew Delhi: Engulfed by a calamitous coronavirus wave, the Government rolled out anti-COVID vaccines for the immunization programme against the deadly...
